2 research outputs found
Time-kill curve of the <i>Mycobacterium tuberculosis</i> H<sub>37</sub>Rv reference strain and multidrug-resistant clinical isolates 71A, 18, 19, 109, 3614, and 64A exposed to rifampicin (RIF), verapamil (VP), and RIF+VP combination for 7 days at 35–37°C.
<p>Time-kill curve of the <i>Mycobacterium tuberculosis</i> H<sub>37</sub>Rv reference strain and multidrug-resistant clinical isolates 71A, 18, 19, 109, 3614, and 64A exposed to rifampicin (RIF), verapamil (VP), and RIF+VP combination for 7 days at 35–37°C.</p
Molecular characterization, drug susceptibility profile, minimum inhibitory concentration, and drug interaction in the <i>M. tuberculosis</i> H<sub>37</sub>Rv reference strain and multidrug-resistant clinical isolates.
<p>R, resistant; NP, not performed; INH, isoniazid; RIF, rifampicin; EMB, ethambutol; PZA, pirazinamid; FICI, fractional inhibitory concentration index; REDCA; Resazurin Drugs Combination Microtiter Assay. VP, verapamil; EtBr, ethidium bromide. Numbers in bold represent synergism.</p><p>Molecular characterization, drug susceptibility profile, minimum inhibitory concentration, and drug interaction in the <i>M. tuberculosis</i> H<sub>37</sub>Rv reference strain and multidrug-resistant clinical isolates.</p